Publications
Methodology for computing the burden of disease of adverse events following immunization Institute of Tropical Medicine
Purpose: Composite disease burden measures such as disability-adjusted life-years (DALY) have been widely used to quantify the population-level health impact of disease or injury, but application has been limited for the estimation of the burden of adverse events following immunization. Our objective was to assess the feasibility of adapting the DALY approach for estimating adverse event burden.
Methods: We developed a practical ...
Pharmacoeconomic impact of adverse events of long-term opioid treatment for the management of persistent pain. Vrije Universiteit Brussel
Adverse events following influenza vaccination: reaction to specific reports and the necessity of a central registration system Institute of Tropical Medicine
The influenza vaccine is considered safe, but information on vaccine-related adverse events is limited and a nationwide overview of adverse events is lacking. In 2006, after deaths occurred in Israel and the Netherlands following influenza vaccination, the Dutch Ministry of Health, Welfare and Sport (VWS) asked the National Institute for Public Health and the Environment (RIVM) twice for a recommendation regarding the continuation of the ...
Incident adverse drug reactions in geriatric inpatients : a multicentred observational study Ghent University
Incidence and risk factors of serious adverse events during antituberculous treatment in Rwanda: a prospective cohort study Institute of Tropical Medicine
Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network KU Leuven
Course of adverse events during short treatment regimen in patients with rifampicin-resistant tuberculosis in Burundi Institute of Tropical Medicine
The introduction of the nine-month short-treatment regimen (STR) has drastically improved outcomes of rifampicin-resistant tuberculosis (RR-TB) treatment. Adverse events (AE) commonly occur, including injectable-induced hearing loss. In Burundi we retrospectively assessed the frequency of adverse events and treatment modifications in all patients who initiated the STR between 2013-2017. Among 225 included patients, 93% were successfully ...